Cite
HARVARD Citation
Kulkarni, R. et al. (2014). Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients. HIV clinical trials. 15 (5), pp. 218-230. [Online].